Target intelligence / Profile preview

Reactive oxygen species-generating pathways (ROS pathways)

Target
ROS pathways
Molecular classification
Enzyme, Mitochondrial complex, Other
01

Overview

Reactive oxygen species (ROS)-generating pathways encompass a broad range of enzymatic and metabolic processes that produce reactive oxygen molecules, such as superoxide, hydrogen peroxide, and hydroxyl radicals. Major biological sources include the NADPH oxidase (NOX) family of enzymes, xanthine oxidase, and the mitochondrial electron transport chain, where ROS are produced as signaling molecules or metabolic byproducts (Bedard K, et al., Physiol Rev, 2007; Murphy MP, Biochem J, 2009). In healthy cells, these pathways are tightly regulated and play vital roles in redox signaling, cell differentiation, and the destruction of pathogens by the immune system (Lambeth JD, Nat Rev Immunol, 2004). However, the dysregulation or overactivation of these pathways leads to oxidative stress, which causes damage to DNA, lipids, and proteins, contributing to the progression of cancer, cardiovascular diseases, and neurodegeneration (Sies H, et al., Annu Rev Biochem, 2017). Therapeutic strategies often target specific components of these pathways, such as NOX inhibitors or xanthine oxidase inhibitors, to reduce pathological ROS levels. A significant challenge in targeting these pathways is maintaining the delicate balance of redox homeostasis, as complete suppression of ROS can impair essential physiological functions and immune responses (Bedard K, et al., Physiol Rev, 2007).

Other names
Pro-oxidant pathwaysROS production systemsOxidative stress pathwaysReactive oxygen species generation
02

Mechanism of action

Inhibition of specific enzymatic sources of ROS, such as NADPH oxidases (NOX) or xanthine oxidase, and modulation of mitochondrial respiratory chain complexes to decrease superoxide production.

03

Biological functions

Signal transductionImmune responseApoptosisCell signalingHomeostasis
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetes
05

Safety considerations

Inhibition of physiological redox signalingPotential for immunosuppressionInterference with oxygen sensingOff-target oxidative damage
06

Interacting drugs

Allopurinol

4 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)8-isoprostaneProtein carbonyls

Beyond the preview

Go deeper on Reactive oxygen species-generating pathways (ROS pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species-generating pathways (ROS pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call